A study of the factors associated with outcome in the patients of Guillain barre syndrome

 

Vijay S Nagaonkar

 

REFERENCES

1. Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol. 1990; 27:S7–S12.
2. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 Nov 5; 366(9497):1653–1666.
3. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis. 1997 Dec; 176(Suppl 2):S92–S98.
4.  Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meché FG. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology. 2000 Feb 8; 54(3):620–625.
5.  Govoni V, Granieri E. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol. 2001 Oct; 14(5):605–613.
6.  McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009; 32(2):150–163.
7.  Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neuro. Nov; 1998 44(5):780–788.
8.  McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet. 1991; 338(8767):593– 597.
9.  McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993 Apr; 33(4):333–342.
10.  Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barré syndrome: relation to antiganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol. 2000 Oct; 48(4): 624–631.
11. Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhoodGuillain-Barré syndrome: a reappraisal. Ann Neurol. 1999 Nov; 46(5):701– 707.
12. Naik KR, Saroja AO, Patil BP. Familial Guillain‑Barré syndrome: First Indian report. Ann Indian Acad Neurol 2012;15:44‑7.
13. Mateen FJ, Cornblath DR, Jafari H, Shinohara RT, Khandit D, Ahuja B, et al. Guillain‑Barré Syndrome in India: Population‑based validation of the Brighton criteria. Vaccine 2011;29:9697‑701.
14.  Cosi V, Versino M. Guillain‑Barré syndrome. Neurol Sci 2006;27 (Suppl 1):S47‑51.
15.  McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain–Barré syndrome worldwide. Neuroepidemiology. 2009; 32(2):150–63. [PubMed: 19088488]
16.  Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, et al. Guillain–Barré syndrome following vaccination in the National Influenza Immunization Program, United States 1976–7. Am J Epidemiol. 1979; 110(11):105–23.
17.  Keenlyside RA, Schonberger LB, Bregman DJ, Bolyai JZ. Fatal Guillain–Barré syndrome after the national immunization program. Neurology. 1980; 30(9):929–33.
18.  Liang X, Li L, Liu D, Li KL, Wu WD, Zhu BP, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med. 2011; 364(7):638–47.
19.  Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990; 27:S21–4.
20.  Hughes RA, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005; 366(4997):1653–66.
21.  Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011; 29(3):599–612.
22. World Health Organization. Acute onset flaccid paralysis. WHO Press; 1993. p. 24-6.
23. Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, Dhawan B. Outcome in childhood Guillain–Barré Syndrome. Ind J Pediatr. 2009; 76(8):795–9.
24.  Peter JV, Gnanamuthu C, Cherian AM, Prebhakar S. Outcomes in the Guillain–Barré syndrome: the role of steroids. J Assoc Physicians India. 1996; 44(3):172–4.
25.  Ho TW, Mishu B, Li Y, Gao CY, Cornblath DR, Griffin JW, et al. Guillain–Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995; 118(Pt 3):597–605.
26. Nachamkin I, Arzate Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, Rodriguez P, et al. Patterns of Guillain–Barré syndrome in children results from a Mexican population. Neurology. 2007; 69(15):1665–71.
27.  Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P, et al. Axonal variant of Guillain–Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology. 2010; 74(7):581–7.
28.   Netto A B,  Taly A B,  Kulkarn G. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation Neurol India 2011; 59: 707-11 .